“Repeat Dose Toxicology Studies: The Applicant conducted oral repeat-dose general toxicology studies (up to 13 weeks) of erdafitinib in rats and dogs.”
✓ VerifiedFDA multi-discipline review, p. 36Source ↗
Why that species
Erdafitinib is pharmacologically active in both rat and dog
“Rats and dogs were selected as relevant species for the pivotal 1- and 3-month repeat-dose toxicology studies since erdafitinib was shown to be pharmacologically active in both animal species.”
“Repeat Dose Toxicology Studies: The Applicant conducted oral repeat-dose general toxicology studies (up to 13 weeks) of erdafitinib in rats and dogs.”
✓ VerifiedFDA multi-discipline review, p. 36Source ↗